TRIM50 and neoplasm: Notably, we observed lower TRIM50 expression and increased M2 macrophage infiltration in primary tumors of GC patients with metastasis compared to those without metastasis (Figure 3C, D), highlighting a potential role for TRIM50 in the modulation of the tumor immune microenvironment and the GC progression.